Table 1 Clinical characteristics of 16 patients with cerebral sparganosis
Age (yrs) /Sex/Ref | Country | Mode of infection | ClinicalManifestation | Enhanced MRI(appearance) | ELISA | Treatment | Outcome/Follow-up time |
|---|---|---|---|---|---|---|---|
29/F/ [16] | India | Uncertain | Seizure/7 mo | Nodular | NP | Craniotomy | Improved/9 mo |
29/M/ [17] | Spain | Water | Seizure/4 y | Ring-like | NP | Craniotomy | Improved /1 y |
71/M/ [18] | Japan | Uncertain | Dysarthria | Bead-like | BLD + | Craniotomy | Improved /2 y |
18/F/ [19] | China | Food | Headache and seizure/1 mo | Bead-like | BLD + CSF + | Abendazole | Improved /1 y |
38/M/ [20] | Japan | Uncertain | Headache, fever and cerebellar ataxia/2 y | Ring-like | BLD + CSF + | NR | NR |
39/M/ [21] | Switzerland | Uncertain | Seizure | Ring-like | BLD + CSF + | Praziquantel | Improved/11 mo |
15/F/ [22] | China | Food | Numbness/1 y seizure/6 mo | Ring-like | BLD + | Craniotomy | Improved /2 y |
24/M/ [23] | Korea | Uncertain | Headache/1 mo | Bead-like | NP | Craniotomy | NR |
62/M/ [24] | Japan | Food | Seizure and hemiparesis/10y | Ring-like | BLD - CSF - | Craniotomy | Improved /5y |
64/M/ [25] | Japan | Food | Seizure and weakness | Ring-like | BLD + CSF + | Craniotomy | NR |
48/M/ [26] | Korea | Food | Weakness and hemianopia | Nodular | BLD + CSF + | Craniotomy | Improved |
80/M/ [27] | Japan | Water | Numbness and weakness | Nodular | NP | Craniotomy | Improved |
21/M/ [28] | America | Uncertain | Confusion/18 mo and seizure once | Ring-like | NP | Craniotomy | Improved |
25/M/ [29] | Germany | Uncertain | Headache and seizure | Ring-like | NP | Craniotomy | Improved |
6/M/ [30] | China | Water | Seizure/2 y | Bead-like | NP | Craniotomy | Improved/6mo |
33/F/PR | China | Uncertain | Headache/10 d | Irregular | BLD + CSF + | Praziquantel | Improved/6mo |